CTCE 0324

Drug Profile

CTCE 0324

Alternative Names: CTCE-0324

Latest Information Update: 16 Jul 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chemokine Therapeutics
  • Class Chemokines; Vascular disorder therapies
  • Mechanism of Action Angiogenesis inducing agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Peripheral vascular disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Peripheral-vascular-disorders in Canada (Parenteral, Injection)
  • 25 Jul 2006 Preclinical data from a media release have been added to the Vascular disorders pharmacodynamics section
  • 07 Mar 2006 Preclinical trials in Peripheral vascular disorders in Canada (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top